SignPath Pharma, Inc. is a company that provides Pharmacy and Therapeutics, Curcumin, Curcuminoid and more. SignPath Pharma, Inc. is headquartered in United States Pennsylvania. SignPath Pharma, Inc. was founded in 2006. SignPath Pharma, Inc. has a total of 176 patents and 1 literature
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of SignPath Pharma, Inc.
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by SignPath Pharma, Inc.
Market Category
Pharmaceuticals
Market Segment
Cardiovascular Drugs
Related Company
OMEICOS Therapeutics GmbH
AETAS Pharma Co., Ltd.
Related Market Sectors
Arrhythmias Pipeline Research Monitor
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for SignPath Pharma, Inc.
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for SignPath Pharma, Inc.
Sign up to view the full data
Free Trial Now
Download
SignPath Pharma, Inc. Frequently Asked Questions
What technical fields has SignPath Pharma, Inc. researched?
SignPath Pharma, Inc. has researched the technical fields related toPharmacy and TherapeuticsCurcuminCurcuminoidDrug developmentAntiarrhythmic agentOrphan drugDrug discoveryClinical trialCardiovascular agentStriatumPLGAHippocampusBrainstemBiotechnologyHuman tumorLead compound
What is SignPath Pharma, Inc.'s total number of patents?
Signpath Pharma is a development stage biotechnology company founded in 2006. Its lead compound is 99.2% pure synthesized curcumin (diferuloylmethane)....